World Coronary Stents Market Reviewed in New Topical Research Report Recently Published at MarketPublishers.com

06 Dec 2011 • by Natalie Aster
World Coronary Stents Market Reviewed in New Topical Research Report Recently Published at MarketPublishers.com

LONDON – The coronary stents market has witnessed patterns of increasing market growth along with some declining phases in its course of span. The global stent market in alignment to the high prevalence of cardiovascular diseases is gaining in its market share year after year. Also, owing the growth in demand for minimally invasive procedures, these stents especially drug-eluting stents are finding rapid increase in their market penetration of more than 60% approximately.

Among the various market across the geographies, U.S forms the largest market for the Coronary stents followed by Europe, Asia-Pacific region countries, Japan and China.

New market research studyGlobal Drug Eluting (DES), Bare Metal (BMS) and Other Coronary Stents Market (2011 - 2016)worked out by Transparency Market Research has been recently published by Market Publishers Ltd.

Report Details:

Title: Global Drug Eluting (DES), Bare Metal (BMS) and Other Coronary Stents Market (2011 - 2016)
Published: November, 2011
Pages: 89
Price: US$ 4,395

The report offers an insightful review of the total coronary stents market and provides coverage of all the major types of coronary stents – i.e. Drug Eluting Stents, Bare Metal Stents and Bio-Absorbable Stents. The key influencing factors for the coronary stent market across the geographies are also analysed. The report includes an in-depth estimations and forecasts for the market sizes (2010-2016) and growth rates for different segments and geographies. The competitive market landscape is discussed along with details on key vendors.

Report Contents:

CHAPTER 1 INTRODUCTION
1.1 KEY TAKES AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 METHODOLOGY


CHAPTER 2 UNDERSTANDING OF THE MARKET
2.1 KEY ELEMENTS OF THE MARKET

CHAPTER 3 MARKET OVERVIEW
3.1 DRIVERS
  3.1.1 ADVANCEMENT IN TECHNOLOGY
  3.1.2 HABITS INFLUENCING THE CORONARY STENT MARKETS
    3.1.2.1 Smoking
    3.1.2.2 Poor Diet and Obesity
    3.1.2.3 Physical Inactivity
    3.1.2.4 Alcohol Intake
  3.1.3 AGING POPULATION - TRIGGER FOR CORONARY STENT MARKETS
  3.1.4 RESTENOSIS – FUELLING CORONARY STENT MARKET
3.2 CHALLENGES
3.3 OPPORTUNITIES
3.4 KEY TRENDS


CHAPTER 4 MARKET SEGMENTATION
4.1 BY PRODUCT
  4.1.1 DRUG ELUTING STENT
    4.1.1.1 Market Metrics
      4.1.1.1.1 Drivers
      4.1.1.1.2 Restraints
        4.1.1.1.2.1 Allergic Reactions
        4.1.1.1.2.2 Long Term Antiplatelet Therapy:
      4.1.1.1.3 Opportunities
    4.1.1.2 Market Size & Growth Rate
    4.1.1.3 Major Players
  4.1.2 BARE-METAL STENT, STAINLESS STEEL
    4.1.2.1 Market Metrics
      4.1.2.1.1 Drivers
      4.1.2.1.2 Restraints
        4.1.2.1.2.1 Potential Side Effects of Stents
      4.1.2.1.3 Opportunity
    4.1.2.2 Market Size & Growth Rates
    4.1.2.3 Major Players
  4.1.3 ABSORBABLE STENTS
    4.1.3.1 Market Metrics
      4.1.3.1.1 Drivers
      4.1.3.1.2 Challenges
      4.1.3.1.3 Opportunities
  4.1.4 BIOACTIVE STENT
    4.1.4.1 Market Metrics
      4.1.4.1.1 Drivers
4.2 BY GEOGRAPHY
  4.2.1 NORTH AMERICA MARKET
    4.2.1.1 Market Metrics
      4.2.1.1.1 Drivers
      4.2.1.1.2 Challenges
      4.2.1.1.3 Opportunities
    4.2.1.2 Market Size & Growth Rates
  4.2.2 EUROPEAN MARKET
    4.2.2.1 Market Metrics
      4.2.2.1.1 Drivers
      4.2.2.1.2 Challenges
      4.2.2.1.3 Opportunities
    4.2.2.2 Market Size & Growth Rates
    4.2.2.3 Major Players
  4.2.3 ASIA-PACIFIC MARKET
    4.2.3.1 Market Metrics
      4.2.3.1.1 Drivers
      4.2.3.1.2 Challenges
    4.2.3.2 Market Size & Growth Rates
    4.2.3.3 Competition Analysis


CHAPTER 5 COMPETITIVE LANDSCAPE

CHAPTER 6 TREND ANALYSIS
6.1 TECHNOLOGY-STRATEGY MAPPING
6.2 INTRODUCTION OF NEWER STENT AND INCREASE IN NUMBER OF PARTICIPANTS: A TREND
6.3 CASE STUDY
  6.3.1 LIFE FOR INNOVATION, LIFE FOR THE BUSINES


CHAPTER 7 CLINICAL TRIALS
7.1 CLINICAL TRIALS: US
7.2 CLINICAL TRIALS: JAPAN
7.3 CLINICAL TRIALS: CHINA
7.4 CLINICAL TRIALS: INDIA
7.5 CLINICAL TRIALS: GERMANY
7.6 CLINICAL TRIALS: FRANCE
7.7 CLINICAL TRIALS: UNITED KINGDOM


CHAPTER 8 COMPANY PROFILES
8.1 BOSTON SCIENTIFIC
  8.1.1 OVERVIEW
  8.1.2 REVENUE DISTRIBUTION OF BOSTON SCIENTIFIC BY GEOGRAPHY
  8.1.3 KEY PRODUCTS
    8.1.3.1 Cardiac rhythm management (CRM) products
    8.1.3.2 Cardiovascular products
    8.1.3.3 Coronary revascularization products
    8.1.3.4 Electrophysiology products
    8.1.3.5 Endoscopy products & Gastroenterology products
    8.1.3.6 Urology/Women's health products
    8.1.3.7 Neuro-modulation products
8.2 JOHNSON & JOHNSON
  8.2.1 OVERVIEW
  8.2.2 JNJ’S BUSINESS SEGMENTATION
  8.2.3 JNJ’S REVENUE BY GEOGRAPHIC
  8.2.4 KEY PRODUCTS SEGMENTS
8.3 ABBOTT LABORATORIES
  8.3.1 OVERVIEW
  8.3.2 BUSINESS SEGMENTS
  8.3.3 DEVELOPMENTS
  8.3.4 REVENUE DISTRIBUTIONS
  8.3.5 PRODUCT PROFILE
8.4 MEDTRONIC, INC.
  8.4.1 OVERVIEW
  8.4.2 SEGMENTS
    8.4.2.1 Medtronic’s Product wise Segmentation
    8.4.2.2 Market Share by Geography
  8.4.3 PRODUCT PROFILE
8.5 BETRIEBSKRANKENKASSE DER B. BRAUN MELSUNGEN
  8.5.1 OVERVIEW
  8.5.2 BUSINESS SEGMENTATION
  8.5.3 PRODUCT PROFILE
8.6 BIORING SA
  8.6.1 OVERVIEW
  8.6.2 BUSINESS SEGMENTS
  8.6.3 PRODUCT PROFILE
8.7 CORNOVA
  8.7.1 OVERVIEW
  8.7.2 PRODUCT PROFILE
8.8 BALTON LTD.
  
8.8.1 OVERVIEW
  8.8.2 PRODUCT PROFILE

More new market research reports by the publisher can be found at Transparency Market Research page.

 

CONTACTS

The Market Publishers, Ltd.

Mrs. Tanya Rezler

Tel: +44 208 144 6009

Fax: +44 207 900 3970

ps@marketpublishers.com

MarketPublishers.com